Any current/future capex/capital investment/strategic investment?

The company plans to add 280 beds in the current financial year as budgeted. Project work is underway for a spoke hospital at Hennur, Bangalore (~60 beds) and a regional greenfield hospital of 100 beds at Rajahmundry, Andhra Pradesh, expected to commence operations towards the end of the next financial year. A new greenfield hospital of 125 beds in Coimbatore is planned, with project work expected to start soon (likely February). In the National Capital Region (NCR), two land parcels in Gurgaon have been purchased, with efforts ongoing to secure possession and progress architectural planning f

Future growth expectations in sales/revenue/volumes?

Mature hospitals showed ~12% top-line growth in nine months but data isn't fully like-to-like due to hospital lifecycle transitions. Expected steady growth in mature hospitals with SSG (Same Store Growth) around 11-12%. Expansion plans include adding ~200–280 beds annually, with new hospitals (e.g., in Hyderabad, Rajahmundry, Coimbatore, Bangalore) planned or underway. New hospitals like those in Hyderabad expected to break even quickly, while others (Sarjapur, Anna Nagar) may take 12-15 months to breakeven. Occupancy targeted at ~55% consolidated, with mature hospitals aiming >60%, de

Future growth expectations in earnings/operating earnings/profits/EPS?

Rainbow Children's Medicare expects continued growth driven by mature and maturing hospitals like Hyderabad, Bangalore, and Chennai. Mature hospitals have shown approx. 11%-12% top-line growth in nine months; however, exact same-store growth is nuanced due to hospital age thresholds. Expansion includes adding ~220 beds in Q4 FY24, with new units anticipated to break even in 12-15 months. Operating revenue grew 9.6% YoY in Q3 FY24; EBITDA grew 10.6%; PAT increased 7.4%. EBITDA margins remain steady (~35% Q3, ~34% YTD), indicating stable profitability. Adoption of hub-and-spoke models optimizes

Rainbow Child.Q3 FY24Healthcare Services

Rainbow Child. Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,280P/E: 48.7Market Cap: ₹14.0K CrSector: Healthcare Services

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Order

N/A

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

Mature hospitals showed ~12% top-line growth in nine months but data isn't fully like-to-like due to hospital lifecycle transitions.
Expected steady growth in mature hospitals with SSG (Same Store Growth) around 11-12%.
Expansion plans include adding ~200–280 beds annually, with new hospitals (e.g., in Hyderabad, Rajahmundry, Coimbatore, Bangalore) planned or underway.
New hospitals like those in Hyderabad expected to break even quickly, while others (Sarjapur, Anna Nagar) may take 12-15 months to breakeven.
Occupancy targeted at ~55% consolidated, with mature hospitals aiming >60%, despite addition of new beds diluting occupancy short term.
Increase in ARPOB driven by better case mix and specialty services, supporting revenue growth even with seasonal occupancy dips.
Market growth fueled by rising awareness, insurance penetration, and expansion into mother and child care segments, including higher demand in Tier 2 cities planned for long term.
Pricing increases linked to inflation (~6-7% annually) expected to provide ongoing revenue support.

Margin guidance

Category 3

Rainbow Children's Medicare expects continued growth driven by mature and maturing hospitals like Hyderabad, Bangalore, and Chennai.
Mature hospitals have shown approx. 11%-12% top-line growth in nine months; however, exact same-store growth is nuanced due to hospital age thresholds.
Expansion includes adding ~220 beds in Q4 FY24, with new units anticipated to break even in 12-15 months.
Operating revenue grew 9.6% YoY in Q3 FY24; EBITDA grew 10.6%; PAT increased 7.4%.
EBITDA margins remain steady (~35% Q3, ~34% YTD), indicating stable profitability.
Adoption of hub-and-spoke models optimizes cost; capex per bed ranges INR65-75 lakhs.
Price hikes (~6-7% annually linked to inflation) and better case mix are driving ARPOB growth.
Mature hospitals aim for occupancy north of 60%, with overall Group occupancy ~55%.
Cost discipline and operational efficiencies support margin resilience despite seasonal variances.
No debt financing planned; expansions funded through strong internal accruals and cash reserves.

See what Rainbow Child. management said on margin guidance — free account, 30 seconds.

Fundraise plans

- The company remains confident in completing all planned capital expenditures through internal accruals without any debt financing. - As of December 31, 2023, Rainbow Children's Medicare Limited had a net cash position of INR 495 crores to support ongoing capex plans. - No mention was made of any current or future fundraising through debt or equity during the call. - The management highlighted they will fund expansions primarily via internal accruals, avoiding additional debt. - They have invested approximately INR 60 crores in capex during the recent quarter from existing resources. In summary, Rainbow Children’s Medicare Limited does not currently plan to raise funds through new debt or equity and aims to fund growth from internal cash flows.

Order book

The transcript provided does not explicitly mention the current or expected order book or pending orders for Rainbow Children's Medicare Limited. Key highlights related to operations and financials include: - The company invested approximately INR 60 crores in capital expenditure during the quarter. - No mention of backlog or order book figures was provided. - The management highlighted ongoing capital expenditure plans being funded internally (without debt). - Discussions centered around hospital expansions, bed additions (around 220 beds in Q4), and growth in mature and new hospitals. - No references to specific pending orders or order book status were made in the call. If detailed information about the order book or pending orders is needed, the management suggested contacting their Investor Relations head, Saurabh Bhandari, for more precise data.

See what Rainbow Child. management said on order book — free account, 30 seconds.

Capex plans

Yes

The company plans to add 280 beds in the current financial year as budgeted.
Project work is underway for a spoke hospital at Hennur, Bangalore (~60 beds) and a regional greenfield hospital of 100 beds at Rajahmundry, Andhra Pradesh, expected to commence operations towards the end of the next financial year.
A new greenfield hospital of 125 beds in Coimbatore is planned, with project work expected to start soon (likely February).
In the National Capital Region (NCR), two land parcels in Gurgaon have been purchased, with efforts ongoing to secure possession and progress architectural planning for new hospitals.
Capex per bed, factoring in inflation, is currently estimated at INR 65-75 lakhs per bed for hub and spoke models.
The company remains confident in completing all planned capital expenditures through internal accruals without any debt financing.

Track Rainbow Child. — get its next earnings analysis in your feed

How does Rainbow Child. rank vs peers in Healthcare Services?

Pro feature

ThisRainbow Child.

Rev 3Mar 3

See where Rainbow Child. sits in Healthcare ServicesSee which companies these are, and every other name in the sector.Open rankings

How does Rainbow Child. rank in Healthcare Services?

Compare Rainbow Child. against every Healthcare Services company (Q3 FY24) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

What Rainbow Child.'s management said in earlier quarters

Others in Healthcare Services this season

KMC Speciality Hospitals (India) Ltd (Q4 FY26)
Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…
KMC Speciality Hospitals (India) Ltd (Q1 FY27)
Q1 FY'27 Revenue from operations: INR 91.8 Cr, up 38% YoY from INR 66.6 Cr in Q1 FY'26. Key concall takeaways from KMC Speciality Hospitals (India) Ltd's Q1…
Suven Life Sciences Ltd (Q1 FY22)
The provided pages of the Suven Life Sciences investor presentation do not contain any specific revenue, sales, or volume figures for any quarter. Key concall…
Vimta Labs Ltd (Q3 FY25)
Q3 FY25 Revenue from Operations: ₹899 Mn . Key concall takeaways from Vimta Labs Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.

Compare:vs Apollo Hospitals Enterprise Ltd vs Max Healthcare vs Manipal Health

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Rainbow Child. Q3 FY24 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does Rainbow Child. rank in Healthcare Services?

Continue your research

What Rainbow Child.'s management said in earlier quarters

Others in Healthcare Services this season